Danen Capital
旦恩资本
Danen Capital (旦恩资本) is an early-stage venture capital firm that appears in the bundle as a co-investor alongside Linear Capital in two deals: the angel round of synthetic-biology startup SynBioRay (贻如生物) in 2023 and the Pre-A round of the same company in 2024 . Beyond these co-investment mentions, elsewhere's corpus does not contain a standalone profile, investment thesis, or team details for the fund.
AI-generated — may contain errors, please verify.
Coverage
AI Tech Drives Down Enzymatic DNA Synthesis Costs, Enzymo Technology Raises Tens of Millions in Angel Round Led by Linear Capital
Achieve de novo DNA synthesis at one-tenth the cost of chemical methods.
线性资本·Linear Capital's angel-round lead investment project, *SynMetabio*, has raised tens of millions of RMB in a Pre-A round, with existing investor Linear Capital continuing to double down as a follow-on investor.
The cost of bio-based leather manufacturing has dropped sharply, and a commercial inflection point could arrive next year, with tens of millions of yuan in revenue.
线性资本·Synthetic biology startup **SynBioRay** (贻如生物) has raised tens of millions of RMB in funding, with **Linear Capital** leading the angel round.
Using synthetic biotechnology to cultivate 100% bio-based leather.
线性资本·
